Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 5, 2007 - Issue 4
Submit an article Journal homepage
153
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

AGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosis

Victor L Serebruany HeartDrug™ Research Laboratories, Osler Medical Center, 7600 Osler Drive, Suite 307, Towson, MD 21204, USA. [email protected]
,
Alex Malinin HeartDrug™ Research Laboratories, Johns Hopkins University Baltimore, MD, USA
,
Christian Eisert HeartDrug™ Research Laboratories, Johns Hopkins University Baltimore, MD, USA
&
Stephen Ong HeartDrug™ Research Laboratories, Johns Hopkins University Baltimore, MD, USA
Pages 635-641 | Published online: 10 Jan 2014

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Stephanie A. Houston, Azizah Ugusman, Sukanya Gnanadesikan & Simon Kennedy. (2017) An investigation of the antiplatelet effects of succinobucol (AGI-1067). Platelets 28:3, pages 295-300.
Read now
Rui Yang, Yu Xu, Peizhong Li, Xin Zhang, Junying Wang, Dongsheng Gu & Yao Wang. (2013) Combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma. OncoTargets and Therapy 6, pages 1139-1146.
Read now

Articles from other publishers (1)

A. Recio-Mayoral, J.-C. Kaski, J. J. V. McMurray, J. Horowitz, D. J. van Veldhuisen & W. J. Remme. (2007) Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovascular Drugs and Therapy 21:6, pages 459-465.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.